World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
82
Citations
27281
World Ranking
1048
National Ranking
92

John P. Quinn publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John P. Quinn sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 386 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John P. Quinn D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John P. Quinn sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 82 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John P. Quinn was affiliated with AstraZeneca in the United Kingdom. Their research spanned various aspects of biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular biology, genetics, and neurology. Their work contributed to multiple subfields, including molecular biology, genetics, neurology, plant science, and cellular and molecular neuroscience.

The scientist's research topics covered several specific areas of study such as:

  • Chromosomal and Genetic Variations
  • Amyotrophic Lateral Sclerosis Research
  • Neurogenetic and Muscular Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • RNA Research and Splicing
  • Genomic variations and chromosomal abnormalities
  • RNA regulation and disease

John P. Quinn's scholarly output included papers in prominent journals. Some of the recent publications were:

  • "Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome" (2021), published in Nature Communications
  • "Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets" (2021), published in JAMA Neurology
  • "Microbial lag phase can be indicative of, or independent from, cellular stress" (2020), published in Scientific Reports
  • "Identification of sixteen novel candidate genes for late onset Parkinson's disease" (2021), published in Molecular Neurodegeneration
  • "Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders" (2020), published in Brain

The scientist also contributed to book publications, notably a volume titled Genomic Structural Variants in Nervous System Disorders released by Humana Press in 2022.

Frequent collaborators in their research included:

  • Vivien J. Bubb
  • Sulev Kõks
  • Abigail L. Pfaff
  • Kimberley J. Billingsley
  • Alfredo Iacoangeli

John P. Quinn's work appeared repeatedly in scientific outlets such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Molecular Sciences
  • Experimental Biology and Medicine
  • Scientific Reports
  • Nature Communications

Best Publications

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

    L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber

  • Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

    Joseph W. Chow;Michael J. Fine;David M. Shlaes;John P. Quinn

  • Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

    Melinda M. Neuhauser;Robert A. Weinstein;Robert Rydman;Larry H. Danziger

  • Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

    Ronald D Gonzales;Paul C Schreckenberger;Mary Beth Graham;Swathi Kelkar

  • Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

    Janis Wiener;John P. Quinn;Patricia A. Bradford;Richard V. Goering

  • Genetic Structures at the Origin of Acquisition of the β-Lactamase blaKPC Gene

    Thierry Naas;Gaelle Cuzon;Maria-Virginia Villegas;Marie-Frédérique Lartigue

  • Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004

    Shawn R. Lockhart;Murray A. Abramson;Susan E. Beekmann;Gale Gallagher

  • First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase

    Maria Virginia Villegas;Karen Lolans;Adriana Correa;Juan Nicolas Kattan

  • Genetic basis for in vivo daptomycin resistance in enterococci

    Cesar A. Arias;Cesar A. Arias;Diana Panesso;Diana Panesso;Danielle M. McGrath;Xiang Qin

  • Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

    Seok Ming Toh;Liqun Xiong;Cesar A. Arias;Cesar A. Arias;Maria V. Villegas

  • Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene.

    Gaëlle Cuzon;Thierry Naas;HaVy Truong;Maria-Virginia Villegas

  • First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America

    Maria Virginia Villegas;Karen Lolans;Adriana Correa;Carlos Jose Suarez

  • Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

    Arthur L Frank;John F Marcinak;P Daisy Mangat;Joyce T Tjhio

  • Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa Infections

    John P. Quinn;Edward J. Dudek;Cathy A. DiVincenzo;David A. Lucks

  • Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic Investigation

    Deborah A. Schiappa;Mary K. Hayden;Marian G. Matushek;Farah N. Hashemi

  • Is there a common water-activity limit for the three domains of life?

    Andrew Stevenson;Jonathan A. Cray;Jim P. Williams;Ricardo Santos

  • Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40

    Karen Lolans;Thomas W. Rice;L. Silvia Munoz-Price;John P. Quinn

  • Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

    M. K. Hayden;K. Rezai;R. A. Hayes;K. Lolans

  • Clinical Problems Posed by Multiresistant Nonfermenting Gram-Negative Pathogens

    John P. Quinn

  • Outbreak of Ceftazidime Resistance Due to a Novel Extended-Spectrum β-Lactamase in Isolates from Cancer Patients

    Louie Naumovski;John P. Quinn;Deborah Miyashiro;Marlynn Patel

  • Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

    J P Quinn;D Miyashiro;D Sahm;R Flamm

  • Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance Program

    Gail S. Itokazu;John P. Quinn;Connie Bell-Dixon;Fred M. Kahan

Frequent Co-Authors

Maria Virginia Villegas
Maria Virginia Villegas El Bosque University
Robert A. Weinstein
Robert A. Weinstein Rush University Medical Center
Karen Bush
Karen Bush Indiana University
Yehuda Carmeli
Yehuda Carmeli Tel Aviv University
Patrice Nordmann
Patrice Nordmann University of Fribourg
Cesar A. Arias
Cesar A. Arias The University of Texas Health Science Center at Houston
David L. Paterson
David L. Paterson University of Queensland
David M. Livermore
David M. Livermore University of East Anglia
Keith A. Rodvold
Keith A. Rodvold University of Illinois at Chicago
Thierry Naas
Thierry Naas University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in pursuing careers related to microbiology, several online degree options offer flexible pathways that can complement a scientific background. For instance, exploring which online mph programs are easiest to get into can be a strategic move for those aiming to enter public health fields quickly while continuing to build expertise.

Career options can also extend into specialized roles such as healthcare and wellness. For example, those passionate about working with families and children might explore becoming a child life specialist, a profession that offers meaningful work and competitive pay as discussed in the guide on how much does a child life specialist make.

Additionally, there are valuable educational opportunities available for individuals who may face admission challenges elsewhere. The article on the best degrees for felons highlights programs suited for those seeking a fresh start, showing that pathways in science and healthcare are accessible to diverse learners.

Healthcare roles like a functional medicine nurse practitioner offer another avenue where biology and patient care intersect. Understanding the functional medicine nurse salary can help prospective students assess the long-term benefits of this career, which blends microbiology knowledge with holistic treatment approaches.

Best Scientists Citing John P. Quinn

Recently Published Articles